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Introduction
Vaccines are one of the most important public health 
interventions for the prevention of infectious diseases [1]. 
Recent vaccines introduced into the US market, such as the 
pneumococcal conjugated vaccine and the rotavirus vaccine, 
continue to demonstrate a significant public health impact by 
reducing hospitalizations and death [2, 3]. For a new vaccine 
to be licensed in the US by the Food and Drug Administration 
(FDA), a trial needs to prove that the vaccine is able to prevent 
the disease for which it was developed. To test the efficacy of 
a new vaccine, studies are performed under well-controlled 
conditions. These studies are usually double-blind, randomized 
control trials (RCT). One of the primary advantages of 
vaccine efficacy studies using the RCT methodology is that 
randomization controls for confounding bias. On the other 
hand, one of the primary disadvantages of the RCT methodology 
is the exclusion of many patients at risk of acquiring the disease 
of interest. For example, these studies are likely to exclude 
patients who are immunocompromised, since these patients 
may not produce enough antibodies after vaccination. Once a 
vaccine has proven efficacy for a selected group of patients, the 
vaccine is further evaluated in a more “real life” study. These 
studies, including all patients at risk of the disease of interest, 
will produce data regarding vaccine effectiveness. 
From an FDA regulatory point of view, vaccine efficacy will be 
tested in a phase III RCT and vaccine effectiveness in a phase IV 
post-license study. One of the most common study  designs used 
to evaluate vaccine effectiveness is a retrospective case-control 
“test-negative” study, where the rate of vaccination among a 
population of patients with the disease is compared to the rate of 
vaccination among a population of patients without the disease 
[4]. 
One important challenge with this approach is that in 
clinical practice, vaccine history data are collected primarily 
via selfreport and some patients do not have an accurate 
recollection of their vaccine history. Inaccurate recollection of 
vaccine history will classify patients in the inappropriate study 
group, incorporating a systematic error in the study, defined 
as recall bias. Some level of recall bias is expected to occur in 
most studies when patients are asked to recall their vaccination 
history. If the level of recall bias is significant, the results of 
the vaccine effectiveness study may be invalid. Adult patients 
hospitalized with community-acquired pneumonia (CAP)with 
community-acquired pneumonia (CAP) may be asked to recall 
their pneumococcal vaccination history in studies evaluating 
effectiveness of pneumococcal vaccination for the prevention of 
hospitalizations. 
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Abstract
Background: Recall bias is likely to occur in vaccine effectiveness studies using self-reported 
vaccination history. The validity of patient-reported vaccination status for adults is not well defined. 
The objective of this study was to evaluate the validity of self-reported pneumococcal vaccination 
history among patients hospitalized with community-acquired pneumonia (CAP).
Methods: Prospective ancillary study of a population-based observational study of hospitalized 
patients with CAP in the city of Louisville. To be included in the analysis, patients had to (i) be reached 
by phone 30-days after discharge from the hospital and (ii) report that they remembered whether 
or not they received a pneumococcal vaccine in the past five years. The vaccination history was 
classified as 1) Subjective: patient recollection, or 2) Objective: vaccination records from insurance 
companies or primary care physicians.
Results: A total of 2,787 patients who recalled their vaccination history were included in the analysis. 
Subjective vaccination history was documented to be inaccurate in 1,023 (37%) patients.
Conclusions: Our study indicates that in adult patients, self-reported data regarding pneumococcal 
vaccination is likely to be inaccurate in one out of three patients.  This level of recall bias may 
incorporate a fatal flaw in vaccine effectiveness studies.
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The level of recall bias in adults regarding their vaccination 
history has not been evaluated.
We designed this study to define the level of inappropriate 
recollection of pneumococcal vaccination in adults hospitalized 
with CAP.
Methods
Study Design & Study Patients: This was an ancillary study
performed during a population-based prospective observational
study of all adults hospitalized with CAP in the city of Louisville,
Kentucky. Patients were included in the primary study if they
had signs and symptoms of lower respiratory infection, an 
infiltrate on chest x-ray, and a final diagnosis of CAP. Patients 
were included in the vaccine recall ancillary study if they were 
able to be reached by phone 30-days after discharge from the 
hospital. Once patients were contacted, they were asked if they 
recalled their pneumococcal vaccination history. Patients with 
no recollection of vaccination history were excluded from the 
study. All participants provided written, informed consent.
Pneumococcal vaccination record verification: Patients with 
recollection of vaccination history were asked if they received 
pneumococcal vaccination (polysaccharide or conjugated). 
Patients were also asked to provide the name of his/her current 
and prior primary care physician and pharmacy where patient 
could have received the vaccine, and current and prior health 
insurance coverage. These primary care physicians and local 
pharmacies were contacted for verification of pneumococcal 
vaccine administration.
In the city of Louisville, pneumococcal vaccination is only 
provided to individuals with health insurance, since it is 
the insurance company that covers the cost of the vaccine. 
Vaccination record was verified with the insurance companies 
for all patients included in the study.
All vaccination records were obtained corresponding with the 
five years prior to hospitalization due to CAP.
Study Definitions: The vaccination history was classified as 1)
Subjective: Patient Recollection, obtained from the patient at
the time of the telephone interview or 2) Objective: Vaccination
Record, obtained by contacting the insurance company, patient’s 
primary care physician, or local pharmacy. The objective
history was considered the gold standard. 
Data Management & Quality: Data collection, management, 
and data quality control were performed by the same research 
team involved in the primary study.
Statistical Analysis: Categorical data were described using 
frequencies and percentages. Medians with interquartile ranges
(IQRs) were used to describe continuous data. P-values were 
calculated to define differences between those with and without 
accurate recall of vaccine history using Chi-squared or Fisher’s
exact tests for categorical variables and the Mann-Whitney 
U-test for continuous variables. Measures of diagnostic accuracy 
were calculated using the objective vaccine history as the gold 
standard and the Kappa statistic was calculated to define the 
agreement between the two data collection methods.
Human Subjects Protection: Participants in the primary 
University of Louisville Pneumonia Study provided their 
consent for inclusion in the vaccine recall ancillary study. 
Results
From a total of 3,378 patients who were contacted by telephone
30 days after hospital discharge due to an episode of CAP, 591
patients were excluded because they did not recall vaccination
history. A total of 2,787 patients who recalled their vaccination
history were included in the analysis.
Subjective vaccination history: Based on the self-reported 
vaccination history, 1,998 patients indicated that they received 
the pneumococcal vaccine prior to hospitalization, and 789 
patients indicated that they did not receive pneumococcal 
vaccination prior to hospitalization.
Objective vaccination history: Based on insurance records 
or primary care physician records, 1,149 patients received the 
pneumococcal vaccination prior to hospitalization, and 1,638 
patients did not receive pneumococcal vaccination prior to 
hospitalization.
Agreement between the two data collection methods were 
as follows: 1,062 patients subjectively recalled obtaining the 
vaccine and were verified via objective methods, and 702 
patients recalled not having received the vaccine and were 
objectively documented to have not received it. In 936 patients 
subjectively recalled obtaining the vaccine were documented 
to not have received the vaccine via objective methods, and 87 
patients recalled not having had the vaccine but were objectively 
defined as having received it. As depicted in Figure 1, from the 
total of 2,787 patients, accurate recollection was documented in 
1,764 patients and inaccurate recollection was documented in 
1,023 patients (37%).
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Fig. 1 Number of patients with accurate versus inaccurate recollection
of pneumococcal vaccination history (n=2,787)
The diagnostic accuracy of subjective vaccination history 
with objective vaccination history is depicted in Table 1. The 
characteristics of the patients with accurate versus inaccurate 
recollection is depicted in Table 2.
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Table 1 Diagnostic accuracy of self-reported (subjective) pneumococcal
vaccine history when compared to medical and health insurance
records (objective) (n=2,787)
Table 2 Characteristics of patients with accurate versus inaccurate
self-reported pneumococcal vaccination history (n=2,787)
Discussion
In this study of hospitalized adult patients with CAP, we 
documented that recall of pneumococcal vaccination history is 
inaccurate for 37% of the patients. Our study indicates that in 
adult patients, the self-report data regarding vaccination history 
is likely to be inaccurate in one out of three patients. Recall 
tended to be worse among older, sicker adults. Previous studies 
have reported similar discordance between self-reported and 
verified vaccination status across a variety of age groups and 
vaccines [5].
The results of our study have vaccine research implications. In
research studies of vaccine efficacy, the administration of the 
vaccine is one of the study interventions; hence, misclassification 
of patients is very unlikely. In vaccine effectiveness studies, 
defining the vaccine status can be challenging. When vaccination 
status is ascertained from adult patients, the potential for 
recall bias is significant, to the point that a fatal flaw may be 
incorporated into the study [6]. 
The results of our study also have clinical implications. The 
majority of health care workers obtained vaccination history 
during a medical interview with the patient. Our study indicates 
that verbal questioning, as a method to obtain vaccination 
history for adults, should be considered unreliable. In clinical 
practice, this may lead to under-vaccination and lack of 
protection, or overvaccination and potential for vaccine hypo-
responsiveness. In addition, a health care worker may look at 
the patient’s electronic medical record to define vaccination 
history. If the information in the medical record was obtained 
from a prior patient interrogation, the possibility of inaccurate 
information will persist. Nearly 20% of all hospitalized patients 
with CAP enrolled in the main population-based study were 
excluded from this ancillary study due to inability to recall 
vaccination history. This lack of recollection intensifies the 
magnitude of using patient self-reported data as a reliable 
source for information about their immunization status. 
Since pneumococcal vaccine administration in the city Louisville
only occurs in those individuals with medical insurance, we 
believe that we were able to accurately capture vaccination 
records by identifying the medical coverage that patients had at 
the time of vaccine administration. However, it is possible that, 
due to a lack of recollection from the patients regarding all the 
insurance coverage over the prior 5 years from enrollment to this 
study, some information may have been missed in relationship 
with vaccine administration.
We evaluated only self-reported history of pneumococcal 
vaccination. Our findings of 37% of patients having inaccurate 
recollection is likely to be similar to the recollection with other 
vaccines. In the US, we have now 13 vaccines recommended 
for adults aged 19 years and older [7]. Considering the number 
of vaccines under clinical research, it is very likely that the 
number of vaccines for adults will continue to expand. The 
need for adults to remember an expanded number of vaccines 
will make recollection of vaccine history more challenging. If 
the patient received all medical care under a single health care 
system, the vaccine history may be obtained objectively from the 
electronic medical record. However, for the majority of adults, 
medical care is fragmented, and objective information regarding 
vaccination history may be difficult to obtain. Until a national 
vaccination registry is available, it will be important for adults 
to have a vaccination card or record where accurate vaccination 
history may be readily accessible.
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